CD81 expression in peripheral blood lymphocytes before and after treatment with interferon and ribavirin in HIV/HCV coinfected patients

HIV Medicine

Volumn 11, Issue 3, 2010, Pages 161-169

  Micheloud, D ^a   Gonzalez Nicolas J ^b   Berenguer, J ^b   Lorente, R ^b   Miralles, P ^b   Lopez J C ^b   Cosin J ^b   Catalan P ^b   Munoz Fernandez A ^b   Resino, S ^a  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

^b HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

Author keywords

HCV genotype; HCV viral load; Hepatitis C virus; Interferon ; Lymphocyte subsets; Sustained virological response

Indexed keywords

ANTIRETROVIRUS AGENT; CD19 ANTIGEN; CD3 ANTIGEN; CD40 ANTIGEN; CD81 ANTIGEN; HLA DR ANTIGEN; INTERLEUKIN 2 RECEPTOR ALPHA; L SELECTIN; PEGINTERFERON ALPHA2A; PEGINTERFERON ALPHA2B; PROTEINASE INHIBITOR; RECOMBINANT ALPHA2A INTERFERON; RECOMBINANT ALPHA2B INTERFERON; RECOMBINANT INTERFERON; RIBAVIRIN; RNA DIRECTED DNA POLYMERASE INHIBITOR; VIRUS RNA;

ADULT; ANTIGEN DETECTION; ANTIGEN EXPRESSION; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; FLOW CYTOMETRY; GENOTYPE; HEPATITIS C; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION; VIRUS LOAD; VIRUS PATHOGENESIS;

ADULT; ANTIGENS, CD; ANTIVIRAL AGENTS; B-LYMPHOCYTES; CROSS-SECTIONAL STUDIES; FEMALE; GENOTYPE; HEPACIVIRUS; HEPATITIS C; HIV INFECTIONS; HUMANS; INTERFERON-ALPHA; LONGITUDINAL STUDIES; LYMPHOCYTE SUBSETS; MALE; RIBAVIRIN; RNA, VIRAL; T-LYMPHOCYTES; VIRAL LOAD;

EID: 75649085314     PISSN: 14642662     EISSN: 14681293     Source Type: Journal    
DOI: 10.1111/j.1468-1293.2009.00758.x     Document Type: Article

References (40)

1. Martin-Carbonero L, Benhamou Y, Puoti M. Incidence and predictors of severe liver fibrosis in human immunodeficiency virus-infected patients with chronic hepatitis C: an European Collaborative Study. Clin Infect Dis 2004, 38:128-133.
2. Bica I, McGovern B, Dhar R. Increasing mortality due to end-stage liver disease in patients with human immunodeficiency virus infection. Clin Infect Dis 2001, 32:492-497.
3. Cacoub P, Geffray L, Rosenthal E, Perronne C, Veyssier P, Raguin G. Mortality among human immunodeficiency virus-infected patients with cirrhosis or hepatocellular carcinoma due to hepatitis C virus in French Departments of Internal Medicine/Infectious Diseases, in 1995 and 1997. Clin Infect Dis 2001, 32:1207-1214.
4. Roe B, Hall WW. Cellular and molecular interactions in coinfection with hepatitis C virus and human immunodeficiency virus. Expert Rev Mol Med 2008, 10:e30.
5. Bartosch B, Vitelli A, Granier C. Cell entry of hepatitis C virus requires a set of co-receptors that include the CD81 tetraspanin and the SR-B1 scavenger receptor. J Biol Chem 2003, 278:41624-41630.
6. Drummer HE, Maerz A, Poumbourios P. Cell surface expression of functional hepatitis C virus E1 and E2 glycoproteins. FEBS Lett 2003, 546:385-390.
7. Stamataki Z, Grove J, Balfe P, McKeating JA. Hepatitis C virus entry and neutralization. Clin Liver Dis 2008, 12:693-712.
8. Serra A, Nuti S, Tavarini S. Coligation of the hepatitis C virus receptor CD81 with CD28 primes naïve T lymphocytes to acquire type 2 effector function. J Immunol 2008, 181:174-185.
9. Deng J, Dekruyff RH, Freeman GJ, Umetsu DT, Levy S. Critical role of CD81 in cognate T-B cell interactions leading to Th2 responses. Int Immunol 2002, 14:513-523.
10. Meroni L, Milazzo L, Menzaghi B. Altered expression of the tetraspanin CD81 on B and T lymphocytes during HIV-1 infection. Clin Exp Immunol 2007, 147:53-59.
11. Witherden DA, Boismenu R, Havran WL. CD81 and CD28 co-stimulate T cells through distinct pathways. J Immunol 2000, 165:1902-1909.
12. Levy S, Todd SC, Maecker HT. CD81 (TAPA-1): a molecule involved in signal transduction and cell adhesion in the immune system. Annu Rev Immunol 1998, 16:89-109.
13. Rosa D, Saletti G, De Gregorio E. Activation of naïve B lymphocytes via CD81, a pathogenetic mechanism for hepatitis C virus-associated B lymphocyte disorders. Proc Natl Acad Sci USA 2005, 102:18544-18549.
14. Levy S, Shoham T. The tetraspanin web modulates immune-signalling complexes. Nat Rev Immunol 2005, 5:136-148.
15. Flint M, Thomas JM, Maidens CM. Functional analysis of cell surface-expressed hepatitis C virus E2 glycoprotein. J Virol 1999, 73:6782-6790.
16. Flint M, von Hahn T, Zhang J. Diverse CD81 proteins support hepatitis C virus infection. J Virol 2006, 80:11331-11342.
17. Mittelbrunn M, Yanez-Mo M, Sancho D, Ursa A, Sanchez-Madrid F. Cutting edge: dynamic redistribution of tetraspanin CD81 at the central zone of the immune synapse in both T lymphocytes and APC. J Immunol 2002, 169:6691-6695.
18. Zuckerman E, Kessel A, Slobodin G, Sabo E, Yeshurun D, Toubi E. Antiviral treatment down-regulates peripheral B-cell CD81 expression and CD5 expansion in chronic hepatitis C virus infection. J Virol 2003, 77:10432-10436.
19. Zuckerman E. Expansion of CD5+ B-cell overexpressing CD81 in HCV infection: towards better understanding the link between HCV infection, B-cell activation and lymphoproliferation. J Hepatol 2003, 38:674-676.
20. Kronenberger B, Herrmann E, Hofmann WP. Dynamics of CD81 expression on lymphocyte subsets during interferon-alpha-based antiviral treatment of patients with chronic hepatitis C. J Leukoc Biol 2006, 80:298-308.
21. Chang LL, Cheng PN, Chen JS, Young KC. CD81 down-regulation on B cells is associated with the response to interferon-alpha-based treatment for chronic hepatitis C virus infection. Antiviral Res 2007, 75:43-51.
22. Jacobs WH, Goldberg SB. Statement on outpatient percutaneous liver biopsy. Dig Dis Sci 1989, 34:322-323.
23. Bedossa P, Poynard T. An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group. Hepatology 1996, 24:289-293.
24. Resino S, Rivero L, Ruiz-Mateos E. Immunity in HIV-1-infected adults with a previous state of moderate-severe immune-suppression and more than 500 CD4 T cell after highly active antiretroviral therapy. J Clin Immunol 2004, 24:379-388.
25. Roque-Afonso AM, Ducoulombier D, Di Liberto G. Compartmentalization of hepatitis C virus genotypes between plasma and peripheral blood mononuclear cells. J Virol 2005, 79:6349-6357.
26. Martinez-Sierra C, Arizcorreta A, Diaz F. Progression of chronic hepatitis C to liver fibrosis and cirrhosis in patients coinfected with hepatitis C virus and human immunodeficiency virus. Clin Infect Dis 2003, 36:491-498.
27. Garcia-Samaniego J, Soriano V, Castilla J. Influence of hepatitis C virus genotypes and HIV infection on histological severity of chronic hepatitis C. The Hepatitis/HIV Spanish Study Group. Am J Gastroenterol 1997, 92:1130-1134.
28. Bianchi FB, Muratori P, Granito A, Pappas G, Ferri S, Muratori L. Hepatitis C and autoreactivity. Dig Liver Dis 2007, 39((Suppl 1)):S22-S24.
29. Ramos-Casals M, Forns X, Brito-Zeron P. Cryoglobulinaemia associated with hepatitis C virus: influence of HCV genotypes, HCV-RNA viraemia and HIV coinfection. J Viral Hepat 2007, 14:736-742.
30. Bower M, Palmieri C, Dhillon T. AIDS-related malignancies: changing epidemiology and the impact of highly active antiretroviral therapy. Curr Opin Infect Dis 2006, 19:14-19.
31. Racanelli V, Frassanito MA, Leone P. Antibody production and in vitro behavior of CD27-defined B-cell subsets: persistent hepatitis C virus infection changes the rules. J Virol 2006, 80:3923-3934.
32. Grant AJ, Lalor PF, Salmi M, Jalkanen S, Adams DH. Homing of mucosal lymphocytes to the liver in the pathogenesis of hepatic complications of inflammatory bowel disease. Lancet 2002, 359:150-157.
33. Hafezi-Moghadam A, Thomas KL, Prorock AJ, Huo Y, Ley K. L-selectin shedding regulates leukocyte recruitment. J Exp Med 2001, 193:863-872.
34. Ley K, Bullard DC, Arbones ML. Sequential contribution of L- and P-selectin to leukocyte rolling in vivo. J Exp Med 1995, 181:669-675.
35. Ishii S, Koziel MJ. Immune responses during acute and chronic infection with hepatitis C virus. Clin Immunol 2008, 128:133-147.
36. Stamataki Z, Shannon-Lowe C, Shaw J. Hepatitis C virus association with peripheral blood B lymphocytes potentiates viral infection of liver derived hepatoma cells. Blood 2008, 113:585-593.
37. Warren A, Le Couteur DG, Fraser R, Bowen DG, McCaughan GW, Bertolino P. T lymphocytes interact with hepatocytes through fenestrations in murine liver sinusoidal endothelial cells. Hepatology 2006, 44:1182-1190.
38. Kronenberger B, Ruster B, Elez R. Interferon alfa down-regulates CD81 in patients with chronic hepatitis C. Hepatology 2001, 33:1518-1526.
39. De Milito A. B lymphocyte dysfunctions in HIV infection. Curr HIV Res 2004, 2:11-21.
40. De Milito A, Nilsson A, Titanji K. Mechanisms of hypergammaglobulinemia and impaired antigen-specific humoral immunity in HIV-1 infection. Blood 2004, 103:2180-2186.